Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
2.485
+0.015 (0.61%)
Mar 9, 2026, 2:04 PM EDT - Market open
Nautilus Biotechnology Employees
Nautilus Biotechnology had 130 employees as of December 31, 2025. The number of employees decreased by 25 or -16.13% compared to the previous year.
Employees
130
Change (1Y)
-25
Growth (1Y)
-16.13%
Revenue / Employee
n/a
Profits / Employee
-$475,815
Market Cap
314.51M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Puma Biotechnology | 172 |
| Cabaletta Bio | 151 |
| X4 Pharmaceuticals | 143 |
| Adlai Nortye | 123 |
| C4 Therapeutics | 110 |
| Rezolute | 75 |
| Protara Therapeutics | 33 |
| Avalo Therapeutics | 23 |
NAUT News
- 3 days ago - Nautilus Biotechnology, Inc. (NAUT) Presents at TD Cowen 46th Annual Health Care Conference Transcript - Seeking Alpha
- 10 days ago - Nautilus Biotechnology, Inc. (NAUT) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 17 days ago - Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference - GlobeNewsWire
- 4 months ago - Nautilus Biotechnology Reports Successful Installation and Testing of its First Field Evaluation Unit at the Buck Institute for Research on Aging - GlobeNewsWire
- 4 months ago - Nautilus Biotechnology, Inc. (NAUT) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Nautilus Biotechnology, Inc. (NAUT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 6 months ago - Nautilus Biotechnology to Participate in Upcoming September Investor Conferences - GlobeNewsWire
- 7 months ago - Nautilus Biotechnology, Inc. (NAUT) Q2 2025 Earnings Conference Call Transcript - Seeking Alpha